Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NDI Notification Failures Concern FDA; Complete Submissions Urged

This article was originally published in The Tan Sheet

Executive Summary

Supplement ingredients being sold without undergoing the NDI notification process rank among top concerns for FDA's Center for Food Safety and Applied Nutrition, according to center Director Robert E. Brackett

You may also be interested in...



NDI Notification Guidance To Assist Puzzled Industry Could Emerge In 2009

FDA tentatively aims this year to complete its guidance for new dietary ingredient notifications, which industry research shows are largely failing to pass the agency's scrutiny

NDI Notification Guidance To Assist Puzzled Industry Could Emerge In 2009

FDA tentatively aims this year to complete its guidance for new dietary ingredient notifications, which industry research shows are largely failing to pass the agency's scrutiny

NDI Notification Guidance To Assist Puzzled Industry Could Emerge In 2009

FDA tentatively aims this year to complete its guidance for new dietary ingredient notifications, which industry research shows are largely failing to pass the agency's scrutiny

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101001

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel